How Reinforcement Learning is Shaping Generative AI Models
There has been one of the most quick on-the-move areas in the field of AI generative artificial intelligence (AI). These models are powered by deep learning and allow them to generate new, seemingly real artifacts of images, text, audio, and video that are often indistinguishable from human-made. There are numerous applications of generative models for […]
VION Biosciences Acquires Echelon Biosciences
VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC […]
Waypoint Bio secures USD 14.5Mln seed funding to turbocharge drug discovery
Waypoint Bio (aka “Waypoint”), a biotechnology company pioneering novel cell therapies for solid tumors using in vivo spatial pooled screening technology, recently announced $14.5 million in seed funding led by Hummingbird Ventures with participation from other institutional investors, including Recode Ventures and pre-seed lead Fifty Years. The FDA recently approved the first ever cell therapy for solid tumors, […]
